Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Important funding for nanomedicine research to improve diagnosis and treatment

Abstract:
Seven new research projects on regenerative medicine and nanomedicine received $16 million in funding. The studies, co-funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA), were announced today at the University of Toronto by Dr. Colin Carrie, Member of Parliament for Oshawa; Dr. Jane Aubin, Scientific Director of the Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis; Mr. Gilles Leclerc, Director General, Space Exploration at the Canadian Space Agency; and Professor Peter Lewis, Associate Vice President (Research) at the University of Toronto. "The Government of Canada is proud to support regenerative medicine and nanomedicine projects that will translate into improved health for Canadians," said Dr. Carrie. "The knowledge that emerges from these research projects could also have wide ranging social and economic benefits."

Important funding for nanomedicine research to improve diagnosis and treatment

Toronto, Canada | Posted on March 17th, 2011

"CIHR is delighted to partner with the Canadian Space Agency to support research aimed at developing technologies and approaches to improve patient outcome," said Dr. Aubin. "The research projects announced today seek to offer new therapies and approaches to treat illnesses and diseases, and ultimately offer better quality of life for patients and their families."

Research on nanomedicine and regenerative medicine is designed to prevent disease and improve human health. Nanomedicine delivers medical technologies that detect or function at the molecular level to diagnose and treat disease, while regenerative medicine stimulates the renewal of bodily tissues and organs or restores function through natural and bioengineered means. Various innovations in these areas have helped combat vascular diseases, cancer, diabetes, multiple sclerosis and other chronic diseases. By promoting research in these areas, CIHR and CSA will be moving Canada to the forefront of modern medical research.

"By working together, CIHR and the CSA are supporting scientific research and innovations that have applications for health care on earth and in space and provide real benefits for Canadians," said Mr. Leclerc. "Our hope is that cutting-edge diagnostic tools will improve astronaut health in space and be adapted for the early detection and treatment of disease here on earth."

"We congratulate the talented researchers who are leading the projects and believe their work on integrating new technologies into health research holds the potential to dramatically change the way we diagnose and treat diseases," said Professor Lewis.

The projects underwent a rigorous and competitive peer review process and were selected according to international standards of scientific excellence.

This funding will enable researchers to potentially:

Identify microlesions in multiple sclerosis, using a new tool for quantifying the cause of the disease and how well a treatment is working, Dr. Daniel Côté, Université Laval;
Create personalized nanomedicines that silence cancer-causing genes, Dr. Petier Cullis, University of British Columbia;
Develop microchip-based devices to analyze prostate cancer markers in blood, Dr. Shana Kelley, University of Toronto;
Generate transplantable, insulin-producing cells from stem cells for diabetes, Dr. Timothy Kieffer, University of British Columbia;
Develop innovative sensorimotor rehabilitation approaches for patients with spinal cord injuries or stroke, Dr. Serge Rossignol, Université de Montréal;
Study how novel therapeutic interventions can regenerate blood vessels, Dr. Michael Sefton, University of Toronto; and,
Develop nanotechnology-enabled image-guided methods of diagnosing and treating lung cancer and vascular diseases, Dr. Gang Zheng, University Health Network.

####

About Canadian Institutes of Health Research
For the past 10 years, the Canadian Institutes of Health Research (CIHR) has supported better health and health care for Canadians. As the Government of Canada's health research investment agency, CIHR enables the creation of evidence-based knowledge and its transformation into improved treatments, prevention and diagnoses, new products and services, and a stronger, patient-oriented health-care system. Composed of 13 internationally recognized Institutes, CIHR supports more than 13,600 health researchers and trainees across Canada. www.cihr-irsc.gc.ca

For more information, please click here

Contacts:
CIHR Media Relations
613-941-4563


Follow us on:
Facebook - Health Research in Canada
Twitter - CIHR_IRSC IRSC_CIHR

Copyright © Canadian Institutes of Health Research

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Watch video about Dr. Kelley's research project

Backgrounder on funded projects

Related News Press

News and information

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

California Research Alliance by BASF establishes more than 25 research projects in three years April 26th, 2017

Videos/Movies

Wood filter removes toxic dye from water April 21st, 2017

Making Batteries From Waste Glass Bottles: UCR researchers are turning glass bottles into high performance lithium-ion batteries for electric vehicles and personal electronics April 19th, 2017

Nano-SPEARs gently measure electrical signals in small animals: Rice University's tiny needles simplify data gathering to probe diseases, test drugs April 17th, 2017

Researchers develop groundbreaking process for creating ultra-selective separation membranes: Discovery could greatly improve energy-efficiency of separation and purification processes in the chemical and petrochemical industries March 15th, 2017

Govt.-Legislation/Regulation/Funding/Policy

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Graphene holds up under high pressure: Used in filtration membranes, ultrathin material could help make desalination more productive April 24th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

NanoMONITOR shares its latest developments concerning the NanoMONITOR Software and the Monitoring stations April 21st, 2017

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Announcements

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

California Research Alliance by BASF establishes more than 25 research projects in three years April 26th, 2017

Aerospace/Space

Space energy technology restored to make power stations more efficient: Scientists use graphene to reinvent abandoned heat energy converter technology March 7th, 2017

Applied Graphene Materials plc - Significant commercial progress in AGM’s three core sectors March 3rd, 2017

Triboelectric Nanogenerators Boost Mass Spectrometry Performance March 1st, 2017

EmTech Asia breaks new barriers with potential applications of space exploration with NASA and MIT February 22nd, 2017

Alliances/Trade associations/Partnerships/Distributorships

California Research Alliance by BASF establishes more than 25 research projects in three years April 26th, 2017

BASF and Landa partner to create revolutionary pigments for automotive coatings: The alliance combines BASF innovations with Landa nano-pigment technology April 5th, 2017

Leti Announces EU/South Korean Project for World’s First 5G-system Prototype: Coinciding with the 2018 Winter Games in PyeongChang, Korea, Prototype Will Be First Time State-of-the-art Terrestrial Wireless Communication Is Seamlessly Combined with Disruptive Satellite Communicati April 4th, 2017

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project